GenVec, Inc. (GenVec), is a biopharmaceutical company using differentiated, proprietary technologies to create therapeutics and vaccines. A key component of GenVec�s strategy is to develop and commercialize its product candidates through collaborations. GenVec is working with companies and organizations, such as Novartis, Merial, and the United States Government to support a portfolio of product programs that address the prevention and treatment of a number of human and animal health concerns. GenVec�s development programs address therapeutic areas, such as hearing loss, balance disorders, and cancer, as well as vaccines against infectious diseases, including respiratory syncytial virus (RSV), herpes simplex virus type 2 (HSV-2), dengue fever, influenza, malaria, and human immunodeficiency virus (HIV). In the area of animal health the Company is developing vaccines against foot-and-mouth disease (FMD).